Avita Medical, Inc. Common Stock Morgan Stanley 24th Annual Global Healthcare Conference

Yeah, I think it is a combination. Being on the board for a few years prior to taking over, I think you can appreciate either the problems or the potential.

I think that the good news is that the problems were few and fixable.

The other good news is that there is a tremendous amount of potential and some great people there, and I do not think investors can really know that, given where they are at. My role over the last 9, 10 months is to make sure that those problems do get solved, that the potential gets made the most of, and that our people understand where we are headed so that we can get the kind of results we have gotten over the last few quarters.

I think at a company this size and at this stage, it's just important to focus, and I think that we focused on the right operating mechanisms.

We did away with a lot of the distractions and disruptions, I think.

Yep. It's deciding what not to do.

It's putting everything from compensation plans in place to the right structure organizationally.

getting the right people in the right seats to execute, and to make sure that the messaging is very consistent, internally and externally. It's very much the same in that we're going to execute, and we're going to be all about growth going forward.

One of the first things I did is really try to understand baseline, what is happening at the company. Are we aware of how our customers buy, why they're buying, why they're not buying? Then seek to become very predictable, to be able to understand what's going to happen and forecast accordingly so that you can impact that forecast along the way. I think for us, we remain in an acute wound care space where our patients are those that suffer incidents and events in any point and time, where we're very consistent as to how they're treated, but also how our people address that need in the marketplace.